About Panaxium
Panaxium is a Healthcare company based in Aix-en-provence (France) founded in 2016 by Brad Schmidt. It operates as a developer of medical equipment for surgeons and neurologists to treat brain injuries. Its chief executive is Brad Schmidt. Panaxium offers products and services including Precision Therapy BMI Platform. Its focus areas include Life Sciences, Neurology, Medical Devices and Screening Devices. Its legal entity is Panaxium SAS. Its competitors include Inscopix, Neurotrack, Brainomix, Artiria and Darmiyan and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
Panaxium was founded in 2016 and focuses on the medical device sector, where bioelectronic medicine technologies are created for neurological applications. A brain-machine interface platform is provided to enable direct interventions in brain injuries during surgical procedures. Operations center on equipment designed specifically for surgeons and neurologists, with no specified geographic headquarters. Leadership is held by founder and CEO Brad Schmidt.
- Headquarters Aix-en-provence, France
- Founders Brad Schmidt
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website panaxium.com
- Social LinkedIn
- Legal Name Panaxium Sas
- InvestorsEuropean Union
& 2 more
Products & Services of Panaxium
Panaxium offers a comprehensive portfolio of products and services, including Precision Therapy BMI Platform.
Platform for brain injury treatment using AI and bioelectronics
Funding Insights of Panaxium
- Total Rounds 4
- First Round $94,895
(Jan 2019)
- Investors Count 3
All 4 funding rounds of Panaxium with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2025 | – | Grant | – | – | |
| Jan 2024 | $96,582 | Grant | – | – | |
| Apr 2023 | – | Seed | – | Ontario Brain Institute | – |
| Jan 2019 | $94,895 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Panaxium
Panaxium has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Ontario Brain Institute and CABHI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Brain research and care innovation is driven in Ontario. | – | braininstitute.ca | Toronto, Canada | |
Innovation in aging and brain health is driven by CABHI. | – | cabhi.com | - | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Panaxium
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Panaxium
1 people are tracked at Panaxium (1 in leadership).
| Name | Role | Group |
|---|---|---|
Brad Schmidt | Founder & CEO | Leadership |
Complete people profiles for Panaxium
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Panaxium
3 dated milestones of Panaxium across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Panaxium is founded.
- Funding First funding round of $95K.
- Funding Latest funding round, Grant,.
Competitors of Panaxium
Panaxium has 9 listed competitors in our database, 8 of them funded. They include Inscopix, Neurotrack, Brainomix, Artiria and Darmiyan, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inscopix.com | 2011 | Palo Alto, United States | $10M | 68 | Miniscope platforms are developed for decoding brain neural circuits. | |
| neurotrack.com | 2012 | Redwood, United States | $57.81M | – | Neurological disorders are diagnosed using eye-tracking assessment tools. | |
| brainomix.com | 2010 | Oxford, United Kingdom | $52.78M | 29 | AI-powered imaging biomarkers are provided for precision medicine applications. | |
| artiria-medical.com | 2019 | Lausanne, Switzerland | $9.19M | – | Micro-navigation systems for stroke surgery are developed. | |
| darmiyan.com | 2015 | San Francisco, United States | $10.09M | – | Platform for presymptomatic diagnosis of neurodegenerative disorders | |
| retispec.com | 2015 | Tel Aviv, Israel | $10M | – | Non-invasive eye scanner for early Alzheimer’s detection is developed. | |
| visievision.com | 2017 | Austin, United States | $12.71M | – | Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery | |
| york-instruments.com | 2015 | York, United Kingdom | – | 37 | Develops innovative magnetoencephalography technologies for neuroimaging. | |
| qmenta.com | 2013 | Barcelona, Spain | $555,000 | – | AI-driven cloud platforms for neuroimaging in clinical trials are utilized. |
Detailed competitors of Panaxium
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Panaxium
The website of Panaxium (panaxium.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▲ 132.5% vs previous month
Top companies in Neurology
10 companies that operate in the same segment as Panaxium (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Panaxium
Complete news archive for Panaxium
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Panaxium
Panaxium was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Panaxium is headquartered in Aix-en-provence, France. It is registered at Aix-en-provence, Provence-alpes-cote D'azur, France.
Brad Schmidt is the current CEO of Panaxium. They have also founded this company.
Panaxium was founded in 2016 and focuses on the medical device sector, where bioelectronic medicine technologies are created for neurological applications. A brain-machine interface platform is provided to enable direct interventions in brain injuries during surgical procedures. Operations center on equipment designed specifically for surgeons and neurologists, with no specified geographic headquarters. Leadership is held by founder and CEO Brad Schmidt.
Panaxium offers Precision Therapy BMI Platform.
Panaxium has 3 investors. Key investors include European Union, Ontario Brain Institute, and CABHI.
Panaxium operates through Panaxium Sas.